Sunday, May 23, 2021

CDC Looking Into Heart Inflammation in Some Young Vaccine Recipients

Some teenagers and young adults who received COVID-19 vaccines experienced heart inflammation, a U.S. Centers for Disease Control and Prevention advisory group said, recommending further study of the rare condition, reports Reuters. 

The CDC's Advisory Committee on Immunization Practices in a statement dated May 17 said it had looked into reports that a few young vaccine recipients, predominantly adolescents and young adults, and predominantly male, developed myocarditis, an inflammation of the heart muscle.

The condition often goes away without complications and can be caused by a variety of viruses, the CDC group said.

Dr. Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, said vaccines are known to cause myocarditis and would be important to monitor to see if it is causally related to the vaccine. It is important to look at the risk-benefit ratio, he added. "Vaccines are going to unequivocally be much more beneficial outweighing this very low, if conclusively established, risk."

So tell us Dr. Adalja, what exactly is the risk for a young person who becomes infected with COVID-19?



  1. When your profession is at stake, risk-reward ratios go out the window. When it's their profession at stake, suddenly we are implored to use a calm analysis of the costs and benefits.

  2. Possessed order followers.

  3. Just to put this out there, the hospital where my wife works has seen at least 14 cases if this since vaccinations began. The doctor quoted here is playing a semantically game when he says myocarditis is rare. It is rare. Very rare. This vaccine is making it much less so.

  4. The death rate for a a young person would be below .028%, that is the statistical overall average. Quoting Martin Armstrong's blog for the number.

  5. What is the potential mechanism for an injection in the shoulder (muscle) to affect the heart muscle? The "scientists" claim that the spike protein remains attached to the cell which expresses the mRNA and that the mRNA only enters the cells near the injection site.